Mitogen-activated Protein Kinase-activated Protein (MAPKAP) Kinase 2 Deficiency Protects Brain from Ischemic Injury in Mice
Open Access
- 1 November 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (46) , 43968-43972
- https://doi.org/10.1074/jbc.m206837200
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Differential Regulation of IL-1β and TNF-α RNA Expression by MEK1 Inhibitor after Focal Cerebral Ischemia in MiceBiochemical and Biophysical Research Communications, 2001
- Use of Suppression Subtractive Hybridization for Differential Gene Expression in StrokeStroke, 2001
- Activation of Mitogen-Activated Protein Kinases after Transient Forebrain Ischemia in Gerbil HippocampusJournal of Neuroscience, 2000
- Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the ratMolecular Brain Research, 2000
- Application of real-time polymerase chain reaction to quantitate induced expression of interleukin-1? mRNA in ischemic brain toleranceJournal of Neuroscience Research, 2000
- Role of immune and inflammatory mediators in CNS injuryDrug News & Perspectives, 2000
- MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemiaProceedings of the National Academy of Sciences, 1999
- MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesisNature Cell Biology, 1999
- A rat model of focal embolic cerebral ischemiaPublished by Elsevier ,1998
- Parallel signal processing among mammalian MAPKsTrends in Biochemical Sciences, 1995